Alterome Therapeutics
Alterome Therapeutics is a clinical-stage precision oncology company founded in 2021 and headquartered in San Diego, California, backed by Canaan Partners. The company designs alteration-specific cancer therapies using deep biology and chemistry expertise paired with an in-house computational chemistry platform ("The Kraken"), a custom CPU/GPU compute array for physics-based molecular simulation and drug design. Its clinical pipeline includes ALTA2618, a mutation-selective inhibitor for AKT1 E17K-driven cancers, and ALTA3263, an oral pan-KRAS ON-state inhibitor targeting more than 90% of KRAS mutations in cancer. Alterome was surfaced through the Canaan Partners portfolio and added to the API Evangelist network as a company profile; it publishes no public developer or API surface.
Index entry only — little beyond a description and a link, and nothing machine-readable enough for an agent to act on without a human reading the site first.
Alterome Therapeutics is tracked in the API Evangelist network. This page is the human-readable profile that sits on top of the machine-readable index we maintain at apis.io.
Every provider in the network is reduced to the same set of machine-readable artifacts — OpenAPI contracts, event specifications, GraphQL schemas, runnable collections, pricing and rate-limit signals, security posture, OAuth scopes, and the agent surfaces (MCP servers and skills) that let software drive the API on its own. We profile them because the interface is the part of a company you can actually inspect: it is a truer signal of what a provider does than any marketing page. From those artifacts we compute the Kin Score — Alterome Therapeutics scores 12.3/100 (minimal), with a separate agent-readiness read of 0/100 (human only). The full breakdown is below, followed by every artifact we hold — each card links through to its machine-readable definition on apis.io.
Kin Score
This is the API Evangelist rating — a single, repeatable read computed from the artifacts on this page. Green fill is points earned; the red track is points possible, so every bar shows earned-versus-possible at a glance.
Kin Score
How this is scored →scored 2026-07-27 · rubric v0.5
Resources
Every other property we hold for Alterome Therapeutics — documentation, portals, status pages, policies, and corporate surface — grouped by the job it does, following the integrator's arc from getting started to running in production.
Commercial 2
Pricing, plans, and the legal terms of use
Company 4
The organization behind the API
Alterome Therapeutics is in the network as a tracked entity. We haven't yet indexed a public API surface for it — when one is published, the artifacts, score, and agent-readiness read will appear here automatically. The source repository is where that profile is built.
← All providers · Data indexed from github.com/api-evangelist/alterome-therapeutics · machine-readable index on apis.io